Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types - Yahoo Finance
4/19/2022 12:00:00 AM3 yearsago
by Checkmate Pharmaceuticals Inc.
by Checkmate Pharmaceuticals Inc.
Proposed ~$250 million all-cash acquisition strengthens Regeneron’s portfolio of diverse and combinable immuno-oncology candidates Lead investigational asset...
Checkmate Pharmaceuticals Inc. Proposed ~$250 million all-cash acquisition strengthens Regenerons portfolio of diverse and combinable immuno-oncology candidates Lead investigational asset vidutolim… [+17466 chars]
full article...